当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析 - 现金流量表

济川药业

(600566)

  

流通市值:265.29亿  总市值:267.02亿
流通股本:9.16亿   总股本:9.22亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,611,542,085.079,285,378,818.037,238,609,644.785,384,117,803.08
收到其他与经营活动有关的现金71,043,393.42435,640,673.19500,618,714.82436,202,691.18
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,682,585,478.499,721,019,491.227,739,228,359.65,820,320,494.26
购买商品、接受劳务支付的现金339,966,490.961,593,300,842.311,279,131,092.69845,180,631.8
支付给职工以及为职工支付的现金294,245,281.18939,022,420.77748,286,916.83543,538,914.67
支付的各项税费373,521,198.511,463,955,858.951,101,814,341.1813,472,258.67
支付其他与经营活动有关的现金880,948,032.063,548,303,353.412,870,483,310.642,050,852,523.04
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,888,681,002.717,544,582,475.445,999,715,661.264,253,044,328.18
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额793,904,475.782,176,437,015.781,739,512,698.341,567,276,166.08
二、投资活动产生的现金流量:
收回投资收到的现金889,000,0005,033,913,092.012,713,082,5002,443,082,500
取得投资收益收到的现金28,821,989.6584,811,095.9131,803,613.0416,869,339.79
处置固定资产、无形资产和其他长期资产收回的现金净额30,242.33694,758.08739,124.783,124.7
投资活动现金流入的平衡项目0000
投资活动现金流入小计917,852,231.985,119,418,9462,745,625,237.742,460,034,964.49
购建固定资产、无形资产和其他长期资产支付的现金25,549,337.56174,335,473.35144,222,826.31107,635,215.97
投资支付的现金901,500,0006,985,000,0004,678,000,0004,408,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计927,049,337.567,159,335,473.354,822,222,826.314,515,635,215.97
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-9,197,105.58-2,039,916,527.35-2,076,597,588.57-2,055,600,251.48
三、筹资活动产生的现金流量:
吸收投资收到的现金--14,305,47814,305,478
取得借款收到的现金283,631,958.411,441,663,600.751,145,480,456.41773,509,834.94
筹资活动现金流入平衡项目0000
筹资活动现金流入小计283,631,958.411,441,663,600.751,159,785,934.41787,815,312.94
偿还债务支付的现金317,438,067.991,405,555,915.49803,513,258.78351,356,307.08
分配股利、利润或偿付利息支付的现金3,581,684.11,217,666,108.81,211,308,339.481,199,264,214.26
支付其他与筹资活动有关的现金1,561,418.8423,582,131.2622,798,939.1610,539,877.1
筹资活动现金流出平衡项目0000
筹资活动现金流出小计322,581,170.932,646,804,155.552,037,620,537.421,561,160,398.44
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-38,949,212.52-1,205,140,554.8-877,834,603.01-773,345,085.5
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额745,758,157.68-1,068,620,066.37-1,214,919,493.24-1,261,669,170.9
加:期初现金及现金等价物余额6,669,362,743.717,737,982,810.087,737,982,810.087,737,982,810.08
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额7,415,120,901.396,669,362,743.716,523,063,316.846,476,313,639.18
补充资料:
净利润-2,536,706,331.49-1,341,293,924.9
资产减值准备-2,881,730.82--
固定资产和投资性房地产折旧-278,867,314.01-139,600,700.37
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-278,867,314.01-139,600,700.37
无形资产摊销-27,831,205.49-12,417,910.21
长期待摊费用摊销-1,221,795.3-64,212.84
处置固定资产、无形资产和其他长期资产的损失--197,641.88-4,733.85
固定资产报废损失-281,712.99-97,662.23
公允价值变动损失--99,202,006.27--51,999,388.12
财务费用-27,273,290.37-15,879,320.48
投资损失--83,540,174.24--15,800,332
递延所得税-22,172,478.51-27,275,749.97
其中:递延所得税资产减少-3,612,933.12-13,282,651.11
递延所得税负债增加-18,559,545.39-13,993,098.86
存货的减少--81,895,122.84--207,560,524.16
经营性应收项目的减少-253,555,395.35-893,169,209.88
经营性应付项目的增加--698,675,991.1--542,073,785.89
其他-10,090,892.02-4,042,886.13
现金的期末余额-6,669,362,743.71-6,476,313,639.18
减:现金的期初余额-7,737,982,810.08-7,737,982,810.08
公告日期2025-04-262025-04-262024-10-262024-08-24
审计意见(境内)标准无保留意见
TOP↑